Patent · US Active

Compositions and methods to regulate Renalase in the treatment of cancer

US11370846B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

Yale University · US

Inventors

Gary Desir · Woodbridge, US
Abigail Hunt · Alameda, US
Jessica O-Rear · Redwood City, US
Peter Flynn · San Diego, US

Key dates

Filing date	Apr 14, 2020
Grant date	Jun 28, 2022
Priority date	—
Expiry date	Apr 14, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/90209
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.